Transgenics to Be a $12 Billion Market by 2012

Kalorama analysts expect transgenics to become a $12 billion market by 2012. The first drug approvals using transgenics are expected this year, resulting in a $225 million market. Read about this new report.

If you are not automatically redirected, follow this link:
http://www.checkbiotech.org/root/index.cfm?fuseaction=news&doc_id=12326&start=1&control=220&page_start=1&page_nr=101&pg=1

Free Subscriptions

Pharma Manufacturing Digital Edition

Access the entire print issue on-line and be notified each month via e-mail when your new issue is ready for you. Subscribe Today.

pharmamanufacturing.com E-Newsletters

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.